No CrossRef data available.
Article contents
The Health Care System as Champion to Curb the Drug Overdose Crisis
Published online by Cambridge University Press: 27 January 2021
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Independent Articles: Commentary
- Information
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 2020
References
US Department of Health
and Human Services, Strategy to Combat Opioid Abuse, Misuse, and
Overdose, available at <https://www.hhs.gov/opioids/sites/default/files/2018-09/opioid-fivepoint-strategy-20180917-508compliant.pdf>
(last visited September 1, 2020).+(last+visited+September+1,+2020).>Google Scholar
Substance Abuse and
Mental Health Administration, Treatment of Stimulant Use Didorders.
PEP20-06-001 (June 2020), available at
<https://store.samhsa.gov/product/Treatment-of-Stimulant-Use-Disorder/PEP20-06-01-001>
(last visited October 30, 2020).+(last+visited+October+30,+2020).>Google Scholar
American Medical
Association. Issue Brief: Reports of Increases in Opioid-Related
Overdose and Other Concerns During COVID Pandemic, available at
<https://www.amaassn.org/system/files/2020-08/issue-brief-increases-in-opioid-related-overdose.pdf>
(last visited September 1, 2020); Centers for Disease Control and
Prevention, Opioid Overdose, Data Analysis and Resources,
available at <https://www.cdc.gov/drugoverdose/data/analysis.html> (last
visited September 1, 2020); Centers for Disease Control and
Prevention, Opioid Overdose, U.S. Prescribing Rate Maps,
available at <https://www.cdc.gov/drugoverdose/maps/rxrate-maps.html> (last
visited August 31, 2020); Centers for Disease Control and
Prevention, CDC Newsroom, New Data Show Significant Changes in Drug
Overdose Death, available at <https://www.cdc.gov/media/releases/2020/p0318-data-show-changes-overdose-deaths.html>
(last visited September 1, 2020).+(last+visited+September+1,+2020);+Centers+for+Disease+Control+and+Prevention,+Opioid+Overdose,+Data+Analysis+and+Resources,+available+at++(last+visited+September+1,+2020);+Centers+for+Disease+Control+and+Prevention,+Opioid+Overdose,+U.S.+Prescribing+Rate+Maps,+available+at++(last+visited+August+31,+2020);+Centers+for+Disease+Control+and+Prevention,+CDC+Newsroom,+New+Data+Show+Significant+Changes+in+Drug+Overdose+Death,+available+at++(last+visited+September+1,+2020).>Google Scholar
National Institute on
Drug Abuse, The Science of Drug Use and Addiction: The Basics,
available at <https://www.drugabuse.gov/publications/media-guide/science-drug-use-addiction-basics>
(last visited September 10, 2020).+(last+visited+September+10,+2020).>Google Scholar
National Academies of
Sciences, Engineering, and Medicine; Health and
Medicine Division; Board on Health Sciences Policy,
Committee on Pain Management and Regulatory Strategies to Address
Prescription Opioid Abuse, Phillips, J.K., Ford, M.A., and Bonnie, R. J., eds. (Washington DC:
National Academies Press,
2017); Evans, E. A., Harrington, C., Roose, R., Lemere, S., and Buchanan, D., “Perceived Benefits and Harms of Involuntary Civil Commitment
for Opioid Use Disorder,” Journal of Law, Medicine &
Ethics 48, no 4 (2020): 718–734; Udwadia, F. R. and Illes, J., “An Ethicolegal Analysis of Involuntary Treatment for Opioid Use
Disorders,” Journal of Law, Medicine & Ethics 48,
no. 4 (2020): 735–740.Google Scholar
National Institute on
Drug Abuse, Drugs, Brains, and Behavior: The Science of Addiction.
20-DA-5605 (last revised June 2020), available at
<https://www.drugabuse.gov/sites/default/files/soa.pdf> (last
visited October 30, 2020).+(last+visited+October+30,+2020).>Google Scholar
Volkow, N., “Addressing the Stigma that Surrounds Addiction,”
available at <https://www.drugabuse.gov/about-nida/norasblog/2020/04/addressing-stigma-surrounds-addiction>
(Last visited September 10, 2020).+(Last+visited+September+10,+2020).>Google Scholar
Yang, L. H., Wong, L. Y., Grivel, M. M., and Hasin, D. S., “Stigma and Substance Use Disorders: An
International Phenomenon,”
Current Opinions in Psychology
30, no. 5 (2017):
378–388; Phillips, L. A. and Shaw, A, “Substance Use More Stigmatized than Smoking and
Obesity,” Journal of Substance Use 18, no. 4 (2013):
247–253.CrossRefGoogle Scholar
National Institute on
Drug Abuse, “Words Matter – Terms to Use and Avoid
When Talking About Addiction,” available at <https://www.drugabuse.gov/nidamed-medical-health-professionals/health-professions-education/words-matter-terms-to-use-avoid-when-talking-about-addiction>
(last visited September 1, 2020); Kelly, J.F., Saitz, R., and Wakeman, S.
“Language, Substance use Disorders, and Policy: The Need
to Reach Consensus on an
‘Addiction-ary,’”
Alcoholism Treatment Quarterly
34, no. 1 (2016):
116–123.Google Scholar
Wakeman, S.E. and Barnett, M. L., “Primary Care and the Opioid-Overdose Crisis
— Buprenorphine Myths and Realities,”
New England Journal of Medicine
379, no. 1 (2018):
1–4.Google Scholar
Yang, et al.,
supra note 8; Hadland, S. E., Park, T. W., and Bagley, S. M., “Stigma Associated with Medication Treatment for
Young Adults with Opioid Use Disorder: A Case
Series,”
Addiction Science & Clinical Practice
13, no. 1 (2018):15; Kelly, J. F., Wakeman, S. E., and Saitz, R., “Stop Talking ‘Dirty’: Clinicians, Language, and
Quality of Care for the Leading Cause of Preventable Death in the United
States,” American Journal of Medicine 128, no. 1 (2015):
8–9.CrossRefGoogle Scholar
Cooper, H.
et al., “When Prescribing Isn’t Enough
— Pharmacy-Level Barriers to Buprenorphine
Access,”
New England Journal of Medicine
383, no. 8 (2020):
703–705.Google Scholar
Nadelmann, E. and LaSalle, L., “Two Steps Forward, One Step Back: Current Harm
Reduction Policy and Politics in the United States,”
Harm Reduction Journal
14, no. 37 (2017):
37.Google Scholar
Harm Reduction
Coalition, “Principles of Harm Reduction,”
available at <https://harmreduction.org/about-us/principles-of-harm-reduction/>
(last visited September 1, 2020).+(last+visited+September+1,+2020).>Google Scholar
Penn, LDI, “Expanding Access to Naloxone: A Review of Distribution
Strategies, available at <https://ldi.upenn.edu/brief/expanding-access-naloxone-review-distribution-strategies>
(last visited September 1, 2020).+(last+visited+September+1,+2020).>Google Scholar
Vowles, K. E., McEntee, M. L., Julnes, P. S., Frohe, T., Ney, J. P., and van der Goes, D. N., “Rates of Opioid Misuse, Abuse, and Addiction in
Chronic Pain: A Systematic Review and Data
Synthesis,”
Pain
156, no. 4 (2015):
569–576.Google Scholar
Hser, Y. I., Mooney, L.J., and Saxon, A. J., et al., “High Mortality Among
Patients With Opioid Use Disorder in a Large Healthcare
System,”
Journal of Addiction Medicine
11, no. 4 (2017):
315–319, doi:
10.1097/ADM.0000000000000312; Kerensky, T. and Walley, A.Y., “Opioid Overdose Prevention and Naloxone Rescue Kits: What We
Know and What We Don’t Know,” Addiction Science &
Clinical Practice 12, no. 1 (2017): 4; Abouk, R., Pacula, R. L., and Powell, D., “Association Between State Laws Facilitating Pharmacy
Distribution of Naloxone and Risk of Fatal Overdose,” JAMA
Internal Medicine 179, no. 6 (2019): 805–11; McClellan, C., Lambdin, B. H., Ali, M. M., Mutter, R., et al., “Opioid-Overdose Laws Asociation with
Opioid Use and Overdose Mortality,” Addictive Behaviors
86 (2018): 90–95.Google Scholar
Evans, et al.,
supra note 5; Udwadia and Illes, supra
note 5; Jain, A., Christopher, P., and Appelbaum, P., “Civil Commitment for Opioid and Other Substance
Use Disorders: Does it Work?”
Psychiatric Services
69, no. 4 (2018):
374–376.CrossRefGoogle Scholar
U.S. Department of Health and
Human Services, Office of the Assistant Secretary for Planning and Evaluation,
Expanding Access to Family-Centered Medication-Assisted Treatment Issue Brief,
available at <https://aspe.hhs.gov/basic-report/expanding-access-family-centered-medication-assisted-treatment-issue-brief>
(last visited September 1, 2020); Orgera, K. and Tolbert, J., “The Opioid Epidemic and Medicaid’s Role in Facilitating
Fccess to Treatment,” available at <https://www.kff.org/medicaid/issue-brief/the-opioid-epidemic-and-medicaids-role-in-facilitating-access-to-treatment/>
(last visited September 1, 2020).+(last+visited+September+1,+2020);+Orgera,+K.+and+Tolbert,+J.,+“The+Opioid+Epidemic+and+Medicaid’s+Role+in+Facilitating+Fccess+to+Treatment,”+available+at+
American Society of
Addiction Medicine, National Practice Guidelines for the Treatment
of Opioid Use Disorder, 2020 Focused Update, available at
<https://www.asam.org/docs/default-source/quality-science/npg-jam-supplement.pdf?sfvrsn=a00a52c2_2>
(last visited September 1, 2020); Mohlman, M.K.
et al., “Impact of Medication-Assisted
Treatment for Opioid Addiction on Medicaid Expenditures and Health Services
Utilization Rates in Vermont,”
Journal of Substance Abuse Treatment
67 (2016):
9–14.CrossRefGoogle Scholar
Substance Abuse and Mental
Health Administration, supra note 2; Gorelick, D.A., “Treatment of Cannabis Use Disorder in Adults,” UpToDate,
July 2020, available at <https://www.uptodate.com/contents/treatment-of-cannabis-use-disorder-in-adults?search=treatment%20of%20cannabis%20use%20disorder&source=search_result&selectedTitle=1~69&usage_type=default&display_rank=1>
(last visited October 30, 2020).+(last+visited+October+30,+2020).>Google Scholar
Sordo, L., Barrio, G., and Bravo, M. J., et al., “Mortality Risk During and
After Opioid Substitution Treatment: Systematic Review and Meta-Analysis of
Cohort Studies,”
BMJ
357 (2017): j1550; Gunne, L. M. and Gronbladh, L., “The Swedish Methadone Maintenance Program: A Controlled
Study,” Drug and Alcohol Dependency 7, no. 3 (1981):
249–256.Google Scholar
Substance Abuse and
Mental Health Services Administration, Key Substance use and Mental
Health Indicators in the United States: Results from the 2019 National Survey on
Drug Use and Health, available at <https://www.samhsa.gov/data/sites/default/files/reports/rpt29393/2019NSDUHFFRPDFWHTML/2019NSDUHFFR1PDFW090120.pdf>
(last visited October 30, 2020).+(last+visited+October+30,+2020).>Google Scholar
National Academies of
Sciences, Engineering, and Medicine, Medications for Opioid
Use Disorder Save Lives (Washington,
DC: The National Academies
Press, 2019): doi:
10.17226/25310.Google Scholar
21 U.S.C. § 823(g)
(2020); Tenn. Code Ann. § 53-11-311 (2020).Google Scholar
21 U.S.C. § 823(g)
(2020).Google Scholar
National Institute on
Drug Abuse, “Understanding Drug Use and Addiction Drug
Facts,” available at <https://www.drugabuse.gov/publications/drugfacts/understanding-drug-use-addiction>
(last visited on September 10, 2020).+(last+visited+on+September+10,+2020).>Google Scholar
Coyne, C. J. and Hall, A. R. “Four Decades and Counting: The Continued Failure of the War on
Drugs, available at <https://www.cato.org/publications/policy-analysis/four-decades-counting-continued-failure-war-drugs>
(last visited September 1, 2020); Report of the Global Commission on
Drug Policy, “War on Drugs” (June 2011),
available at <https://www.globalcommissionondrugs.org/wp-content/themes/gcdp_v1/pdf/Global_Commission_Report_English.pdf>
(last visited September 9, 2020).+(last+visited+September+1,+2020);+Report+of+the+Global+Commission+on+Drug+Policy,+“War+on+Drugs”+(June+2011),+available+at++(last+visited+September+9,+2020).>Google Scholar
National Institute on Drug
Abuse, supra note 30; Report of the Global Commission on Drug
Policy, supra note 31; Drug Policy Alliance, “A Brief
History of the Drug War,”available at <https://www.drugpolicy.org/issues/brief-history-drug-war>
(last visited September 1, 2020).+(last+visited+September+1,+2020).>Google Scholar
E. Nadelmann and L. LaSalle,
supra note 14; National Judicial Opioid Task
Force, “Convening, Collaborating, Connecting: Courts as
Leaders in the Crisis of Addiction,” available at
<https://www.ncsc.org/__data/assets/pdf_file/0018/15840/njotf_final_report_111819.pdf>
(last visited September 10, 2020).+(last+visited+September+10,+2020).>Google Scholar